What Are the Regulatory and Safety Considerations?
Due to the potential health risks associated with immunosuppressive agents, regulatory bodies like the Environmental Protection Agency (EPA) and the Food and Drug Administration (FDA) establish guidelines for acceptable exposure levels. Safety assessments typically include evaluating both short-term and long-term effects on the immune system. Companies must follow stringent testing protocols to ensure that their products do not pose immunotoxic risks to humans or wildlife.
